Vaccine developers Pfizer Inc and Moderna Inc on Monday rejected U.S. President Donald Trump's invitation to attend a White House "Vaccine Summit".

Shares in Pfizer fell on Monday after rival drugmaker Moderna said its experimental vaccine against COVID-19 was 94.5% effective and that it can be stored at normal fridge temperatures.

Trump's physician, Sean Barbabella, shared news of the president's COVID vaccination in a letter to White House press ...

Moderna stock is trading higher Wednesday afternoon, lifted by positive sentiment across the pharmaceutical sector.

Children under 12 need different versions of Covid vaccines, but many pharmacies and pediatricians’ offices aren’t stocking ...

Amid confusion over this year's updated COVID-19 vaccines, we explain what's different this year and who experts say should ...

Shares of global pharmaceutical company Pfizer (NYSE:PFE) jumped 5.9% in the afternoon session after the company reached an ...

Last year’s updated COVID-19 vaccines helped prevent severe outcomes, including hospitalizations and deaths, according to data from a large study of U.S. military veterans published on Wednesday.

Moderna is producing its first made-in-Canada COVID-19 shots at facilities in Laval, Que. and Cambridge, Ont. The Laval ...

Globe Investor value reports provide a daily price target for more than 9,000 stocks on the TSX, Nasdaq, and NYSE. Used by ...

Pfizer will buy Metsera for $4.9 billion plus milestone payments, adding incretin, amylin, and oral obesity drug candidates to its pipeline.

Updated COVID shot led to less severe illness, fewer hospitalizations last year, US study finds – Nation and World News | ...